Title of article
Bevacizumab in combination with irinotecan plus fluorouracil plus leucovorin chemotherapy prolongs survival but increases adverse events in people with metastatic colorectal cancer: Abstracted from: Hurwitz H, Fehrenbacher L, Novotny W, et al. Bevacizumab
Author/Authors
Choti، نويسنده , , Michael A.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2004
Pages
6
From page
715
To page
720
Journal title
Cancer Treatment Reviews
Serial Year
2004
Journal title
Cancer Treatment Reviews
Record number
1834598
Link To Document